InformationAccessibility Statement
Site Colors Display(* Works in modern browsers like Chrome & Firefox)Normal DisplayAdjusted for color blindedAdjusted for hard vision
Close

About the product

enovidTM is a novel spray for protection against viruses, developed by the company Sanotize. The spray releases a liquid compound that produces nitric oxide (NO) into the nasal cavity. This is a molecule that naturally occurs in the body and has been found highly effective in disinfecting against various microbes, including fungi, bacteria, and of course viruses.

Laboratory figures prove that the product eliminates 99% of viruses within approximately 2 minutes.

In addition, the results of a trial held on COVID-19 patients in the United Kingdom showed that the spray reduced the concentration of the virus in patients’ bodies by 95% in 24 hours and 99% in 72 hours. The spray was developed in Canada, is produced in Israel, and is available over-the-counter at pharmacies.

  • Eliminates viruses in the nasal cavity – their main “gateway” to the airways.
  • Significantly reduces viral load in the body.
  • Easy to use and made of natural ingredients only.
  • Approved for use by the Ministry of Health from the age of 12.

 

*Winchester et al. Clinical Efficacy of nitric oxide nasal spray (NONS) for the treatment of mild COVID-19 infection. Journal of Infection 2021: 83(2) 237-279.

 

 

Viral load is established according to the number of viral particles in the human body.

The greater the load, the greater the risk of disease with acute symptoms.
When the viral load decreases, the chances of spreading the disease and infecting others around you decrease too.


Trials have proved the effectiveness of the enovidTM spray in reducing the viral load of COVID-19 positive patients

*Winchester et al. Clinical Efficacy of nitric oxide nasal spray (NONS) for the treatment of mild COVID-19 infection. Journal of Infection 2021: 83(2) 237-279.

Viral load is established according to the number of viral particles in the human body.

The greater the load, the greater the risk of disease with acute symptoms.
When the viral load decreases, the chances of spreading the disease and infecting others around you decrease too.


Trials have proved the effectiveness of the EnoVid spray in reducing the viral load of COVID-19 positive patients

*Winchester et al. Clinical Efficacy of nitric oxide nasal spray (NONS) for the treatment of mild COVID-19 infection. Journal of Infection 2021: 83(2) 237-279.

 

Pharmacies where enovidTM is available

enovidTM spray may be bought in a range of pharmacies nationwide.

 

Pharmacies where EnoVid is available

EnoVid spray may be bought in a range of pharmacies nationwide.

From the press

The world says yes to NO: the molecule discovered 50 years ago is beginning to fulfill its potential

When the NO molecule (nitric oxide) was discovered in the 1970s, it was met with suspicion; even after earning the reputation of a “magic molecule” and allowing its discovers to win the Nobel Prize, pharmaceutical companies were in no hurry to adopt it. Now all that is changing. Nobel Prize laureate Prof. Ferid Murad, one of the discoverers of the molecule, in an interview with Globes, discusses its potential for treating diseases, from cancer to diabetes

The world says yes to NO: the molecule discovered 50 years ago is beginning to fulfill its potential

When the NO molecule (nitric oxide) was discovered in the 1970s, it was met with suspicion; even after earning the reputation of a “magic molecule” and allowing its discovers to win the Nobel Prize, pharmaceutical companies were in no hurry to adopt it. Now all that is changing. Nobel Prize laureate Prof. Ferid Murad, one of the discoverers of the molecule, in an interview with Globes, discusses its potential for treating diseases, from cancer to diabetes